Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gareth G Lavery

Showing results (51-60 of 110) with videos related to

Pageof 11
Sort By:
Endocrinology|July 8, 2016
Male 11β-HSD1 Knockout Mice Fed Trans-Fats and Fructose Are Not Protected From Metabolic Syndrome or Nonalcoholic Fatty Liver DiseaseDean P Larner, Stuart A Morgan, Laura L Gathercole, et al.
European Journal of Endocrinology|May 18, 2022
Increased systemic and adipose 11β-HSD1 activity in idiopathic intracranial hypertensionConnar S J Westgate, Keira Markey, James L Mitchell, et al.
Journal of Neurology|August 22, 2021
Obstructive sleep apnoea in women with idiopathic intracranial hypertension: a sub-study of the idiopathic intracranial hypertension weight randomised controlled trial (IIH: WT)Andreas Yiangou, James L Mitchell, Matthew Nicholls, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 4, 2014
11β-HSD1 is the major regulator of the tissue-specific effects of circulating glucocorticoid excessStuart A Morgan, Emma L McCabe, Laura L Gathercole, et al.
Annals of the Rheumatic Diseases|November 9, 2020
Local steroid activation is a critical mediator of the anti-inflammatory actions of therapeutic glucocorticoidsChloe Fenton, Claire Martin, Rachel Jones, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 10, 2020
Succinate dehydrogenase deficiency in a chromaffin cell model retains metabolic fitness through the maintenance of mitochondrial NADH oxidoreductase functionKatarína Kľučková, Alpesh Thakker, Lisa Vettore, et al.
Metabolomics : Official Journal of the Metabolomic Society|January 19, 2021
Metabolic consequences for mice lacking Endosialin: LC-MS/MS-based metabolic phenotyping of serum from C56Bl/6J Control and CD248 knock-out miceEmily G Armitage, Alan Barnes, Kieran Patrick, et al.
Endocrinology|May 2, 2013
Regulation of lipid metabolism by glucocorticoids and 11β-HSD1 in skeletal muscleStuart A Morgan, Laura L Gathercole, Claire Simonet, et al.
Frontiers in Rehabilitation Sciences|October 3, 2022
The Impact of Slice Interval and Equation on the Accuracy of Magnetic Resonance Image Estimation of Quadriceps Muscle Volume in End Stage Liver DiseaseJonathan I Quinlan, Clare Jones, Emma Bissonnette, et al.
Blood|October 2, 2013
Cell-intrinsic regulation of murine dendritic cell function and survival by prereceptor amplification of glucocorticoidAnnelise Soulier, Sandra M Blois, Shivajanani Sivakumaran, et al.
Pageof 11

Showing results (51-60 of 110) with videos related to

Sort By:
Pageof 11
Endocrinology|July 8, 2016
Male 11β-HSD1 Knockout Mice Fed Trans-Fats and Fructose Are Not Protected From Metabolic Syndrome or Nonalcoholic Fatty Liver DiseaseDean P Larner, Stuart A Morgan, Laura L Gathercole, et al.
European Journal of Endocrinology|May 18, 2022
Increased systemic and adipose 11β-HSD1 activity in idiopathic intracranial hypertensionConnar S J Westgate, Keira Markey, James L Mitchell, et al.
Journal of Neurology|August 22, 2021
Obstructive sleep apnoea in women with idiopathic intracranial hypertension: a sub-study of the idiopathic intracranial hypertension weight randomised controlled trial (IIH: WT)Andreas Yiangou, James L Mitchell, Matthew Nicholls, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 4, 2014
11β-HSD1 is the major regulator of the tissue-specific effects of circulating glucocorticoid excessStuart A Morgan, Emma L McCabe, Laura L Gathercole, et al.
Annals of the Rheumatic Diseases|November 9, 2020
Local steroid activation is a critical mediator of the anti-inflammatory actions of therapeutic glucocorticoidsChloe Fenton, Claire Martin, Rachel Jones, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 10, 2020
Succinate dehydrogenase deficiency in a chromaffin cell model retains metabolic fitness through the maintenance of mitochondrial NADH oxidoreductase functionKatarína Kľučková, Alpesh Thakker, Lisa Vettore, et al.
Metabolomics : Official Journal of the Metabolomic Society|January 19, 2021
Metabolic consequences for mice lacking Endosialin: LC-MS/MS-based metabolic phenotyping of serum from C56Bl/6J Control and CD248 knock-out miceEmily G Armitage, Alan Barnes, Kieran Patrick, et al.
Endocrinology|May 2, 2013
Regulation of lipid metabolism by glucocorticoids and 11β-HSD1 in skeletal muscleStuart A Morgan, Laura L Gathercole, Claire Simonet, et al.
Frontiers in Rehabilitation Sciences|October 3, 2022
The Impact of Slice Interval and Equation on the Accuracy of Magnetic Resonance Image Estimation of Quadriceps Muscle Volume in End Stage Liver DiseaseJonathan I Quinlan, Clare Jones, Emma Bissonnette, et al.
Blood|October 2, 2013
Cell-intrinsic regulation of murine dendritic cell function and survival by prereceptor amplification of glucocorticoidAnnelise Soulier, Sandra M Blois, Shivajanani Sivakumaran, et al.
Pageof 11